Trial Profile

A phase 2 study of MOS-118

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 12 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MOS 118 (Primary)
Indications Sleep apnoea syndrome
Focus Therapeutic Use

Most Recent Events

12 Jun 2025 New trial record
09 Jun 2025 According to Mosanna Therapeutics media release, company announced the close of $80 million in Series A funding. Series A funding to advance MOS118 through Phase 2 clinical trials and the new funding will support the advancement of MOS118 through Phase 2 development while also supporting expansion of Mosanna's pipeline.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com